ERBB2 and breast carcinoma: In our in vitro study we investigated the interaction between Trastuzumab, a monoclonal antibody used for the treatment of Her-2 positive breast cancer and an aqueous fermented mistletoe extract, frequently used by cancer patients as supportive therapy.